Medicare Enrolled
Dr. Promila Dhanuka, M.D.
Hematology & Oncology · Redding, CA
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Dhanuka from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Dhanuka?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Dhanuka
Dr. Promila Dhanuka is a hematology & oncology specialist in Redding, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Dhanuka performed 133,676 Medicare services across 2,268 unique beneficiaries.
Between the years covered by Open Payments, Dr. Dhanuka received a total of $10,306 from 60 pharmaceutical and/or device companies across 478 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in hematology & oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Dhanuka is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice
▲ Top 5% volume in CA
$10,306 industry payments
Medicare Practice Summary
Medicare Utilization ↗133,676
Medicare services
Top 5% in CA for hematology & oncology
2,268
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~7,036 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
91,202 | $0 | $2 |
| Abatacept infusion (Orencia) An injection of abatacept administered under the direct supervision of a physician. This code is used for Medicare when the drug is not self-administered. |
6,677 | $34 | $150 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
6,208 | $0 | $1 |
| Golimumab infusion (Simponi Aria) Administration of golimumab medication directly into a vein. This code specifies the dosage amount of 1 milligram for intravenous delivery. |
5,564 | $10 | $49 |
| Rituximab biosimilar injection, 10 mg An injection of rituximab-abbs, a biosimilar medication, administered in a 10 mg dose. |
3,496 | $35 | $203 |
| Anti-nausea injection (ondansetron/Zofran) | 3,138 | $0 | $0 |
| Infliximab infusion (Remicade) An injection of infliximab, excluding biosimilar versions, administered in a 10 mg dose. |
3,100 | $26 | $123 |
| Epoetin alfa injection (Retacrit) for anemia An injection of a biosimilar form of epoetin alfa used for non-end-stage renal disease purposes. The dose administered is 1000 units. |
3,000 | $6 | $37 |
| Denosumab injection (Prolia/Xgeva) | 2,760 | $19 | $90 |
| Infliximab-abda biosimilar injection, 10 mg This code represents the administration of a 10 mg dose of infliximab-abda, a biosimilar medication. It covers the injection of this specific pharmaceutical product. |
2,270 | $27 | $128 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
2,019 | $95 | $463 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
708 | $24 | $109 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
596 | $1 | $6 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
495 | $53 | $242 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
385 | $107 | $493 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
314 | $23 | $105 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
290 | $144 | $647 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
262 | $11 | $52 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
211 | $7 | $47 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
164 | $121 | $600 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
131 | $17 | $78 |
| New patient office visit, complex (60-74 min) | 125 | $173 | $791 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
120 | $53 | $241 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
98 | $1 | $10 |
| Irrigation of implanted venous access device This procedure involves flushing an implanted venous access device to clear blockages or maintain patency. It ensures the device remains functional for delivering medications or fluids. |
95 | $20 | $97 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
82 | $45 | $208 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
81 | $13 | $58 |
| Venipuncture for blood collection A procedure to draw blood from a vein for medical testing or analysis. |
56 | $71 | $367 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
29 | $19 | $87 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
81.1% high complexity
16.8% medium
2.1% routine
Industry Payment Transparency
Open Payments through 2024 ↗$10,306
Total received (2018-2024)
Avg $1,472/year across 7 years
Top 32% in CA for hematology & oncology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
60
Companies
478
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$8,708 (84.5%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$1,598 (15.5%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$770
2023
$1,928
2022
$1,849
2021
$1,448
2020
$928
2019
$1,592
2018
$1,791
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Daiichi Sankyo Inc.
$238
ABBVIE INC.
$121
Incyte Corporation
$119
Janssen Biotech, Inc.
$88
Ipsen Biopharmaceuticals, Inc
$47
Novartis Pharmaceuticals Corporation
$44
Regeneron Healthcare Solutions, Inc.
$27
Eisai Inc.
$27
Genentech USA, Inc.
$25
AstraZeneca Pharmaceuticals LP
$21
E.R. Squibb & Sons, L.L.C.
$13
Top 3 companies account for 62.0% of 2024 payments
All-time payments by company (2018-2024) ›
PFIZER INC.
$983
Janssen Biotech, Inc.
$781
Novartis Pharmaceuticals Corporation
$709
Incyte Corporation
$530
Daiichi Sankyo Inc.
$456
Seagen Inc.
$428
E.R. Squibb & Sons, L.L.C.
$415
AstraZeneca Pharmaceuticals LP
$413
Amgen Inc.
$389
Astellas Pharma US Inc
$376
Celgene Corporation
$369
Intuitive Surgical, Inc.
$367
Eisai Inc.
$301
Genentech USA, Inc.
$271
Seattle Genetics, Inc.
$237
Ipsen Biopharmaceuticals, Inc
$216
Merck Sharp & Dohme Corporation
$212
Kite Pharma, Inc.
$208
EISAI INC.
$188
Coherus Biosciences Inc.
$142
ABBVIE INC.
$138
GENZYME CORPORATION
$135
Gilead Sciences, Inc.
$119
Takeda Pharmaceuticals U.S.A., Inc.
$117
Organon LLC
$104
Merck Sharp & Dohme LLC
$100
ARRAY BIOPHARMA INC
$99
Lilly USA, LLC
$98
AbbVie, Inc.
$95
Teva Pharmaceuticals USA, Inc.
$94
Regeneron Healthcare Solutions, Inc.
$93
Rigel Pharmaceuticals, Inc.
$89
TerSera Therapeutics LLC
$84
Alexion Pharmaceuticals, Inc.
$82
Kyowa Kirin, Inc.
$72
SERVIER PHARMACEUTICALS LLC
$67
Pharmacyclics LLC, An AbbVie Company
$61
Sobi, Inc
$58
EMD Serono, Inc.
$54
Taiho Oncology, Inc.
$54
Boehringer Ingelheim Pharmaceuticals, Inc.
$44
Lexicon Pharmaceuticals, Inc.
$41
AbbVie Inc.
$36
Janssen Pharmaceuticals, Inc
$34
Bayer HealthCare Pharmaceuticals Inc.
$34
TESARO, Inc.
$25
Exelixis Inc.
$24
Allergan Inc.
$24
TAIHO ONCOLOGY, INC.
$23
PharmaEssentia USA Corporation
$23
AVEO Pharmaceuticals, Inc.
$23
GlaxoSmithKline, LLC.
$22
Aveo Pharmaceuticals, Inc.
$21
MEDIVATION FIELD SOLUTIONS LLC
$20
JAZZ PHARMACEUTICALS INC.
$20
Secura Bio, Inc.
$20
Shire North American Group Inc
$18
Alnylam Pharmaceuticals Inc.
$18
MorphoSys, US Inc.
$15
Karyopharm Therapeutics Inc.
$15
Top 3 companies account for 24.0% of all-time payments
Associated products mentioned in payments ›
ADCETRIS · AFINITOR · AKEEGA · Abraxane · Alecensa · Aliqopa · Aranesp · Avastin · BENDEKA · BESREMI · BOSULIF · BRAFTOVI · CALQUENCE · Cabometyx · DARZALEX · DAURISMO · DOPTELET · Da Vinci Surgical System · ELITEK · EMPLICITI · ENHERTU · ERLEADA · Enhertu · Entyvio · Erleada · FARESTON · FASLODEX · FOTIVDA · Fabhalta · Farydak · GAZYVA · GILOTRIF · GIVLAARI · IBRANCE · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Imbruvica · JADENU · JAKAFI · JAYPIRCA · JEVTANA · KANJINTI · KEYTRUDA · KISQALI · Kyprolis · LIBTAYO · LINZESS · LONSURF · LORBRENA · LUMAKRAS · Lenvima · Lonsurf · MEKINIST · MONJUVI · MYLOTARG · NINLARO · Nplate · OCREVUS · ONTRUZANT · ONUREG · OPDIVO · Ocrevus · Onivyde · PADCEV · PEMAZYRE · PIQRAY · POTELIGEO · PROMACTA · Padcev · Pomalyst · Quzyttir · REBLOZYL · REMICADE · RETEVMO · RYDAPT · Revlimid · Rezlidhia · SANCUSO · SARCLISA · SCEMBLIX · SOLIRIS · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · TAGRISSO · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · TUKYSA · Tavalisse · Tecentriq · Tibsovo · ULTOMIRIS · Udenyca · VARUBI · VENCLEXTA · VERZENIO · VONVENDI · Venclexta · XALKORI · XARELTO · XPOVIO · XTANDI · Xermelo · Xtandi · Yescarta · ZEJULA · ZENPEP · ZEPZELCA · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (84%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Hematology & oncology specialists within 10 mi
4
Per 100K population
2.2
County median income
$71,931
Nearest hospital
MERCY MEDICAL CENTER REDDING
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Dhanuka is a mixed practice specialist, with above-average Medicare volume (top 5% in CA), with low-engagement industry engagement, with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Dhanuka experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Dhanuka performed 91,202 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Dhanuka receive payments from pharmaceutical companies?
Yes. Dr. Dhanuka received a total of $10,306 from 60 companies across 478 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Dhanuka's costs compare to other hematology & oncology specialists in Redding?
Dr. Dhanuka's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Dhanuka) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Hematology & Oncology Specialists in Redding
Browse hematology & oncology specialists in Redding ranked by procedure volume and transparency data.
Highest volume
Top Hematology & Oncology Specialists in CA
Hematology & oncology specialists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematology & Oncology Specialists in CA
Which CA hematology & oncology specialists receive the most from drug and device companies.
By company
PFIZER INC. Payments to Doctors
See all physicians who received payments from PFIZER INC.
By company
Janssen Biotech, Inc. Payments to Doctors
See all physicians who received payments from Janssen Biotech, Inc.
By company
Novartis Pharmaceuticals Corporation Payments to Doctors
See all physicians who received payments from Novartis Pharmaceuticals Corporation.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology